Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Based on the results of the Bacterial Reverse Mutation Test it is concluded that EDA-DOPO is not mutagenic in the Salmonella typhimurium test strains TA97a, TA98, TA100, TA102 and TA1535 in the absence and presence of metabolic activation under the experimental conditions in the pre-sent study.

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2016-09-23 - 2016-10-07
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay
Species / strain / cell type:
S. typhimurium TA 98
Species / strain / cell type:
S. typhimurium TA 100
Species / strain / cell type:
S. typhimurium TA 102
Species / strain / cell type:
S. typhimurium TA 1535
Species / strain / cell type:
S. typhimurium TA 97
Metabolic activation:
with and without
Metabolic activation system:
S9-mix
Test concentrations with justification for top dose:
DMSO was chosen as vehicle because the best result of a homogeneous and pipettable suspension was achieved with the solvent DMSO. ; tThis solvent does not have any ef-fects on the viability of the bacteria or the number of spontaneous revertants in the tested concentrations.
The following nominal concentrations were prepared for the first experiment:
5000 µg/plate, 1500 µg/plate, 500 µg/plate, 150 µg/plate and 50 µg/plate.
The following nominal concentrations were prepared for the second experiment:
5000 µg/plate, 2500 µg/plate, 1250 µg/plate, 625 µg/plate, 313 µg/plate and 156 µg/plate.
Vehicle / solvent:
DMSO
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
yes
Positive controls:
yes
Positive control substance:
sodium azide
benzo(a)pyrene
other: 4-Nitro-1,2-phenylene diamine, 2-Amino-Anthracene
Evaluation criteria:
The colonies were counted visually and the numbers were recorded. A validated spread-sheet software (Microsoft Excel®) was used to calculate mean values and standard devia-tions of each treatment, solvent control and positive control.
The mean values and standard deviations of each threefold determination was calculated as well as the increase factor f(l) of revertant induction (mean revertants divided by mean spontaneous revertants) of the test item solutions and the positive controls. Additionally, the absolute number of revertants (Rev. Abs.) (mean revertants minus mean spontaneous revertants) was given.
A substance is considered to have mutagenic potential, if a reproducible increase of re-vertant colonies per plate exceeding an increase factor of 2 in at least one strain can be observed. A concentration-related increase over the range tested is also taken as a sign of mutagenic activity.
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 97
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid

First Experiment

Strain

TA97a

TA98

TA100

TA102

TA1535

Induction

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

Demin. water

Mean

87

88

19

19

106

113

387

383

24

23

sd

21.1

20.4

3.6

2.1

18.0

18.5

76.6

18.0

1.0

5.6

DMSO

Mean

73

105

12

17

105

110

356

357

26

24

sd

1.5

39.0

1.0

4.0

15.3

9.2

6.9

40.3

3.5

6.4

Positive
Controls*

Mean

351

388

296

61

647

1176

760

1088

365

145

sd

175.5

90.6

69.3

9.8

16.2

259.6

28.8

350.9

96.0

23.7

f(I)

4.81

3.70

24.67

3.59

6.10

10.69

2.13

3.05

15.21

6.04

5000 µg/plate

Mean

104

90

14

12

116

112

291

251

27

28

sd

11.1

25.7

3.2

1.5

5.3

17.1

28.4

37.2

4.0

8.9

f(I)

1.42

0.86

1.17

0.71

1.10

1.02

0.82

0.70

1.04

1.17

1500 µg/plate

Mean

86

95

16

13

108

108

231

273

25

26

sd

23.1

23.0

1.5

2.6

15.5

16.7

34.9

102.2

5.2

6.5

f(I)

1.18

0.90

1.33

0.76

1.03

0.98

0.65

0.76

0.96

1.08

500 µg/plate

Mean

111

104

16

15

110

113

336

331

24

37

sd

7.0

30.8

2.6

2.1

16.2

11.1

38.2

67.2

7.4

7.5

f(I)

1.52

0.99

1.33

0.88

1.05

1.03

0.94

0.93

0.92

1.54

150 µg/plate

Mean

104

108

12

12

105

115

279

235

23

27

sd

22.1

18.0

1.0

1.0

14.8

6.4

48.4

63.8

5.5

3.6

f(I)

1.42

1.03

1.00

0.71

1.00

1.05

0.78

0.66

0.88

1.13

50 µg/plate

Mean

91

87

13

13

92

119

335

259

26

22

sd

18.0

18.1

2.6

1.0

15.9

3.1

6.1

22.0

4.0

4.5

f(I)

1.25

0.83

1.08

0.76

0.88

1.08

0.94

0.73

1.00

0.92

Second Experiment

Strain

TA97a

TA98

TA100

TA102

TA1535

Induction

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

Demin. water

Mean

108

91

9

14

100

96

264

331

19

12

sd

7.0

8.7

1.5

4.0

2.0

9.2

13.9

22.0

2.9

1.5

DMSO

Mean

91

89

13

10

89

98

257

309

13

14

sd

14.4

4.9

3.0

1.2

6.0

12.5

6.1

37.8

1.2

2.1

Positive
Controls*

Mean

665

448

372

79

444

480

769

1525

291

64

sd

40.5

150.3

44.0

6.2

40.6

48.0

10.1

113.5

74.4

14.0

f(I)

7.31

5.03

28.62

7.90

4.44

4.90

2.99

4.94

15.32

4.57

5000 µg/plate

Mean

79

99

16

15

66

78

375

393

14

17

sd

6.4

15.3

1.0

4.4

8.7

10.4

30.6

93.8

3.2

4.2

f(I)

0.87

1.11

1.23

1.50

0.74

0.80

1.46

1.27

1.08

1.21

2500 µg/plate

Mean

96

108

12

14

75

88

311

377

13

15

sd

20.0

2.6

4.4

3.5

10.2

9.6

91.4

26.6

2.3

2.9

f(I)

1.05

1.21

0.92

1.40

0.84

0.90

1.21

1.22

1.00

1.07

1250 µg/plate

Mean

90

101

11

13

79

84

377

372

12

15

sd

23.6

16.5

2.0

1.5

4.4

4.2

36.3

50.0

2.1

3.6

f(I)

0.99

1.13

0.85

1.30

0.89

0.86

1.47

1.20

0.92

1.07

625 µg/plate

Mean

95

91

11

14

70

81

393

445

9

16

sd

10.6

22.2

1.5

4.6

0.6

15.3

76.4

64.7

0.6

3.5

f(I)

1.04

1.02

0.85

1.40

0.79

0.83

1.53

1.44

0.69

1.14

312 µg/plate

Mean

81

109

13

15

86

88

299

341

15

15

sd

9.1

12.1

2.5

3.5

21.2

7.0

39.5

40.1

2.1

3.5

f(I)

0.89

1.22

1.00

1.50

0.97

0.90

1.16

1.10

1.15

1.07

156 µg/plate

Mean

90

122

15

18

71

88

309

305

11

16

sd

3.6

6.0

2.0

1.7

5.5

9.6

20.5

14.0

1.2

2.6

f(I)

0.99

1.37

1.15

1.80

0.80

0.90

1.20

0.99

0.85

1.14

Conclusions:
Based on the results of this study it is concluded that EDA-DOPO is not mutagenic in the Salmonella typhimurium test strains TA97a, TA98, TA100, TA102 and TA1535 in the ab-sence and presence of metabolic activation under the experimental conditions in the pre-sent study.
Executive summary:

Two valid experiments were performed.

 

The study procedures described in this report were based on the most recent OECD and EC guidelines.

The test item EDA-DOPO was tested in theSalmonella typhimuriumreverse mutation assay with five strains ofSalmonella typhimurium(TA97a, TA98, TA100, TA102 and TA1535). The test was performed in triplicates in the presence and absence of S9-mix (rat liver S9-mix induced by Aroclor 1254).

 

In the first experiment, EDA-DOPO (dissolved in DMSO) was tested up to concentrations of 5000 µg/plate in the absence and presence of S9-mix (0.74 % final concentration in the treatment)in the strains TA97a, TA98, TA100, TA102 and TA1535 using the plate incorporation method.

EDA-DOPOshowed no precipitates on the plates at any of the concentrations.

The bacterial background lawn was not reduced at any of the concentrations and no relevant decrease in the number of revertants was observed in all bacteria strains. The test item EDA-DOPO showed no signs of toxicity towards the bacteria strains in both the absence and presence of metabolic activation.

The results of this experiment showed that none of the tested concentrations showed a significant increase in the number of revertants in all tested strains, in the presence and the absence of metabolic activation.

 

On the base of the first experiment, EDA-DOPO was tested up to concentrations of 5000 µg/plate in the absence and presence of S9-mix (0.74% final concentration in the treatment)in all bacteria strain using the pre-incubation method.

EDA-DOPOshowed no precipitates on the plates at any of the concentrations.

The bacterial background lawn was not reduced at any of the concentrations and no relevant decrease in the number of revertants was observed in all bacteria strains. The test item EDA-DOPO showed no signs of toxicity towards the bacteria strains in both the absence and presence of metabolic activation.

The results of this experiments showed that the test item EDA-DOPO caused no increase in the number of revertants in all bacteria strains compared to the solvent control, in both the absence and presence of metabolic activation. The test item EDA-DOPO did not induce a dose-related increase in the number of revertants colonies in all strains, in the presence and absence of metabolic activation.

 

Based on the results of this study it is concluded that EDA-DOPO is not mutagenic in theSalmonella typhimuriumstrains TA97a, TA98, TA100, TA102 and TA1535 in the absence and presence of metabolic activation under the experimental conditions in this study.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

Based on the results of the bacterial reverse mutation assay EDA-DOPO has not to be classified for mutagenicity.